Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
Source: Pixabay.com

Second Ever Cancer Treatment Based on Biomarkers Approved by FDA

On November 26, 2018, a new drug was given accelerated approval by the FDA. Not only that, but it was granted orphan drug designation and breakthrough therapy designation. The drug…

Continue Reading Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
source: pixabay.com

Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage

According to a story from the Peterborough Telegraph, James Willis received a disaster diagnosis on his first Valentine's Day after getting married at age 29. James had been worried about…

Continue Reading Man With Soft Tissue Sarcoma is Refusing to Let His Diagnosis Spoil His Recent Marriage
NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence
Source: https://pixabay.com/en/code-programming-hacking-html-web-820275/

NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence

The biopharmaceutical research and development company CytRx Corporation, announced an exciting new update early this month involving the company’s work with aldoxorubicin, a new drug for treatment in soft tissue sarcomas.…

Continue Reading NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence